Associate Professor Jemma Hopewell
Contact information
| jemma.hopewell@ndph.ox.ac.uk | |
| Tel | +44 (0)1865 743661 |
My connections
- British Heart Foundation Intermediate Basic Science Research Fellow
- CTSU Senior Scientist in Genetic Epidemiology and Clinical Trials
- International Stroke Genetics Consortium Chair of METASTROKE
- Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly (CATCH ME) Collaborating Partner
- Lp(a) Foundation Scientific Advisory Board
- THRIVE Research Group
- REVEAL Research Group
- PROCARDIS Research Group
- Genetic epidemiology of Lp(a), kidney function and vascular disease Research Group
- Using population biobanks and pharmacogenomics to enhance clinical trial design Research Group
- Investigating genetic and non-genetic determinants of heart rhythm Research Group
- Genetic determinants of chronic kidney disease and vascular risk Research Group
Jemma Hopewell
BSc (Hons) MSc PhD (Cantab)
Associate Professor & Senior Scientist in Genetic Epidemiology and Clinical Trials
- BHF Intermediate Basic Science Research Fellow
- MSc in Global Health Science Module Lead: Genetic Epidemiology
Associate Professor Jemma leads a medical statistics and genetic epidemiology team in a programme of research focusing on the use of genetic and clinical trial-based studies to investigate the causes and treatments for cardiovascular disease and arrhythmias. She has particular interests in determining predictors of patient response to therapy, using genetics to improve our understanding of drug targets and disease mechanisms, and genomic characterisation of vascular disease and its risk factors, particularly Lp(a). Jemma leads and collaborates on numerous projects involving CTSU's vascular mega-trials (e.g. HPS, SEARCH, THRIVE, REVEAL), large-scale studies and biobanks (e.g. PROCARDIS, UK Biobank), and international consortia (e.g. METASTROKE, CARDIoGRAMplusC4D, GoLEAD, CATCH-ME). She is a member of the Lp(a) Foundation Scientific Advisory Board, of various clinical trial and genetic study Steering and Analysis Committees, and is currently the Chair of METASTROKE (a collaboration of the International Stroke Genetics Consortium), as well as co-ordinating the MSc in Global Health Science Genetic Epidemiology module.